Framework Journal · one stock, one dated entry

Recorded 2026-07-19 · Permanent

General Motors logoGeneral Motors GM

An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.

In plain words · General Motors Company designs, builds, and sells trucks, crossovers, cars, and automobile parts worldwide.

The label
Markup

read at $76.07

General Motors holds its Markup at $76.07.

PHINPOOPSC
  • PHPhase · the trend structure carries the Markup label
  • INInsiders · insiders sold, $37,192,225, latest filing 2026-05-26
  • POPositioning · no disclosures inside 60 days, left as found
  • OPOptions · no verdict drawn today, left as found
  • SCScreen · does not pass the values gate
  • edge confirmed
  • edge broken
  • edge forming

Each arm is one independent read. Conviction is not a single call, it is how many edges converge.

The investor read · the season, not the day

As held on the ledger · 2026-07-19
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 2 days
Price$76.07
Valuation27.76 trailing · 5.37 forward price to earnings
Values screenFAIL · score 10.0
Beta1.31

The values screen, explained · five checks, plain English

Does not pass. Debt ratio

  • Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
  • Debt load Interest-bearing debt is 46.7% of its assets, above the one-third ceiling the screen allows. Fail
  • Interest-bearing cash Cash held in interest-bearing accounts and securities is 2.0% of assets, under the one-third limit. Pass
  • Receivables Money owed to the company is 28.2% of assets, under the 49% limit. Pass
  • Revenue purity Only 0.5% of revenue comes from non-compliant sources — under the 5% line. Pass

Five checks adapted from AAOIFI screening standards — business activity plus four balance-sheet ratios. All five must pass for ethical clearance.

The opportunity · what the numbers say it is worth

Our framework reads AVOID — it trades at roughly a 35% discount to our $102.69 fair value, weak competitive moat.

Read at
$76.07
27.76 P/E · 5.37 fwd
Our fair value
$102.69
35% discount
Analyst target (avg)
$100.00
+31% to current
Target low $60.00Analyst target rangeTarget high $131.00
▲ current $76.07 · | average target

Price history & projections · where it has been, where the models see it going

$139$83$27TODAY5y agoPROJECTIONAnalyst high$131.00 +64%Our fair value$102.69 +29%Analyst avg$100.00 +26%Conservative$89.81 +13%

The valuation journey · where the price sits against fair value and the Street

Current
$76.07
you are here
Conservative
$89.81
+18%
Analyst avg
$100.00
+31%
Our fair value
$102.69
+35%
Analyst high
$131.00
+72%

Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Revenue growth-0.90%
Profit margin1.38%
Debt to equity199.05
Analyst consensusBuy · 26 covering

Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.

The business, in plain words · what the numbers mean

GM's low multiple hides a cyclical trap

Picture a shiny truck on the forecourt with a bargain price sticker. You kick the tyres and the numbers look tempting at 5.4 times forward earnings, yet the business is shrinking revenue, scraping 1 percent profit margins and posting just 4 percent return on equity with a weak moat.

We pass for clear reasons. The ethical screen flags excessive debt and the company sits in a deeply cyclical industry where low multiples often mark peak earnings rather than a genuine bargain. Analyst targets sit higher but that does not change the underlying picture.

The combination of thin returns, negative growth and leverage makes this look more like a value trap than an opportunity. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E5.4x
very cheap relative to earnings
Trailing P/E27.8x
a premium valuation
Revenue growth-0.9%
revenue is shrinking
Profit margin1.4%
barely profitable
Return on equity4.0%
a modest return on shareholder capital
Debt to equity1.99
a meaningful debt load worth watching
Current ratio1.15
adequate liquidity, worth monitoring
Beta1.31
moves a little more than the market
Market cap$68.6B
Employees156,000

The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.

Plain-English interpretation of our own screen data. Analysis, not advice.

Latest news · what the market is reading on GM

Headlines from third-party outlets, linked for reference — not our reporting, not advice.

Related securities · others in GM's space worth a look

Screened names in the same industry · explore each on its own page.

Where & how to trade · wherever in the world you are

GM trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The trader read · the latest dated commentary

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 7.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 64%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (26 analysts) rates it buy, with a mean price target of $94. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis. Entered 2026-07-19 · Markup

The dated journal · newest first, never edited

2026-07-19 Markup $76.07 -7.4% Entry 6

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 7.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 64%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (26 analysts) rates it buy, with a mean price target of $94. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-18 Markup $82.11 +0.0% Entry 5

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 64%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (26 analysts) rates it buy, with a mean price target of $94. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-17 Markup $82.11 +0.0% Entry 4

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 64%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (26 analysts) rates it buy, with a mean price target of $94. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-16 Markup $82.11 +0.0% Entry 3

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 64%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (26 analysts) rates it buy, with a mean price target of $94. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-03 Markup $82.11 +0.0% Entry 2

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.

2026-07-02 Markup $82.11 Entry 1

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The insider ledger · Form 4 filings, as filed

Most recent filings · GM
DateInsiderTitleTypeSharesValue
2026-05-26 Barra Mary T Chair, CEO Sale 453,402 $37,192,225
2026-05-26 Jacobson Paul A EVP, CFO Sale 40,000 $3,200,000
2026-05-22 Harvey Rory EVP Sale 85,146 $7,049,302
2026-02-17 REUSS MARK L President 230,058 $9,539,850
2026-02-17 REUSS MARK L President 480,724 $38,709,455
2026-02-06 BARRA MARY TERESA Chief Executive Officer 521,778 ·
2026-02-06 REUSS MARK L President 373,607 ·
2026-02-06 JACOBSON PAUL A Chief Financial Officer 220,753 ·
2026-02-06 HATTO CHRISTOPHER Officer 29,434 ·
2026-02-06 HARVEY RORY Officer 176,542 ·

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The political ledger · congressional disclosures

Disclosures naming GM
DatePoliticianPartyTypeAmount
15 May2026 Ro Khanna Democrat buy 1K–15K

What holding actually paid · price plus dividends

If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $75.13 +6.0% $0.18 $1,063 +6.3%
2 months $76.25 +4.5% $0.18 $1,047 +4.7%
3 months $73.29 +8.7% $0.18 $1,089 +8.9%
6 months $80.48 -1.0% $0.36 $994 -0.6%
1 year $48.49 +64.3% $0.66 $1,656 +65.6%
2 years $46.65 +70.8% $1.17 $1,733 +73.3%
3 years $35.13 +126.7% $1.59 $2,312 +131.2%
5 years $59.06 +34.9% $1.95 $1,382 +38.2%

Historical returns from market close data. Past performance does not guarantee future results.

This entry now belongs to the ledger. Whatever GM does next, these words stay.

General Motors · GM · Markup · $76.07
Recorded 2026-07-19 · before the outcome · scored mechanically

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry Indicators Options Calendar Composites Boycott Tracker Convergence Screener Fed Tracker Explore All Is It Halal? Earnings Calendar Dividend Screener Country Guides Glossary Join Free →

Get our weekly market brief free.